INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Clinical trials for INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS) explained in plain language.
Never miss a new study
Get alerted when new INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS) trials appear
Sign up with your email to follow new studies for INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Crohn's patients when first drug fails
Disease control Recruiting nowThis study looks at whether a drug called guselkumab can help people with moderate to severe Crohn's disease who did not improve or could not tolerate another drug called ustekinumab. About 60 adults will receive guselkumab and be followed for 52 weeks. The main goal is to see ho…
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Hidden kidney risk in IBD: 6,000-Person study launches
Knowledge-focused Recruiting nowThis study will compare kidney function in 3,000 adults with Crohn's disease or ulcerative colitis to 3,000 adults without these conditions. Participants will provide blood and urine samples and have a kidney ultrasound. The goal is to learn how common kidney problems are in IBD …
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC